USPTO serial 79075468
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
NL-2333 CK Leiden, NL
NL-2333 CK Leiden, NL
NL-2333 CK Leiden, NL
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of bleeding and for tissue sealing; pharmaceutical preparations and substances for use as tissue sealants; haemostatic pharmaceutical compositions; pharmaceutical powder compositions for use as tissue sealants and/or as haemostatic compositions; pharmaceutical compositions for topical application to wounds; pharmaceutical compositions for topical application during surgical procedures for the treatment of bleeding and for tissue sealing; wound dressings; surgical dressings; bandages for dressing wounds; medicated wound dressings impregnated with tissue sealants and/or haemostatic compositions; medicated bandages impregnated with tissue sealants and/or haemostatic compositions; wound dressings, surgical dressings and bandages for dressing wounds, all incorporating tissue sealants and/or haemostatic compositions; pharmaceutical preparations and substances for use in delivery of drugs, genes, other therapeutic products or diagnostic agents, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment of internal bleeding; blood platelet substitutes; pharmaceutical compositions for coating blood vessels for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical compositions for intravascular administration for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical dry powder compositions comprising fibrin polymer for coating the internal surface of blood vessels for the prevention and treatment of cardiovascular diseases and disorders | SECTION 71 - CANCELLED | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments for administration of pharmaceutical compositions, namely, drug delivery systems; drug delivery systems, sold empty, for the delivery of pharmaceutical compositions for the treatment of bleeding and/or tissue sealing; drug delivery systems, sold empty, for the topical delivery of powdered pharmaceutical tissue sealants and/or haemostatic compositions; drug delivery systems, sold empty, for the delivery of tissue sealants to an internal or external surface of a patient; drug delivery systems, sold empty, for the delivery of haemostatic compositions by spraying; drug delivery systems, sold empty, for the delivery of pharmaceutical tissue sealants and/or haemostatic compositions during surgical procedures; surgical, medical, dental and veterinary apparatus and instruments for the prevention and treatment of cardiovascular diseases and disorders; drug delivery systems, sold empty, for intravascular delivery of pharmaceutical compositions for the prevention and/or treatment of cardiovascular diseases and disorders | SECTION 71 - CANCELLED | — |
| 042 | Pharmaceutical drug development services; design services of new drug delivery systems; development of pharmaceutical formulations; scientific research and industrial research services in the field of pharmaceuticals and drug delivery systems | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 17, 2020 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Apr 17, 2020 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 17, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 28, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 28, 2019 | INPC | INVALIDATION PROCESSED | — |
| Mar 20, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 20, 2018 | C71T | CANCELLED SECTION 71 | — |
| Aug 29, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 7, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 7, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 13, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 13, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 27, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 7, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 22, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 18, 2011 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 18, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 18, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 18, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 10, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 10, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 10, 2011 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 25, 2011 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 4, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 4, 2011 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 2, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2011 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 10, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 20, 2011 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 20, 2010 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 20, 2010 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 15, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 15, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jun 29, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 22, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 29, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 29, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 24, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 23, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 11, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 7, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 4, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |